Article
Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.
Antimicrobial agents and chemotherapy - 1 Dec 1998
Franz R, Kelly S L, Lamb D C, Kelly D E, Ruhnke M, Morschhäuser J
Abstract excerpt
From each of two AIDS patients with oropharyngeal candidiasis, five Candida albicans isolates from recurrent episodes of infection which became gradually resistant against fluconazole during antimycotic treatment were analyzed for molecular changes responsible for drug resistance. In both patients, a single C. albicans strain was responsible for the recurrent infections, but the CARE-2 fingerprint pattern of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
